Oral administration of this dendrimer significantly lowered the level of pro-inflammatory cytokines in rhesus macaques, demonstrating the potential of nano-assisted TLR4 antagonist for controlled resolution of infection-associated inflammation [229]. The gene discussed is TLR4; the disease is infection.